KL
Kaleido Biosciences, Inc.
KLDO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $12.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
36 /100
Moderate Profitable years 0
Beta -1.17x
EPS volatility 47.42%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na KLDO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Wingertzahn
Employees
76
Headquarters
Lexington
Nadcházející události
02 LIS
Earnings
Upcoming earnings report